Emcure Pharmaceuticals Ltd. (EMCURE): Emcure Pharmaceuticals Share Price Falls 3.27%: Price Action, Sector and Peer Analysis

Emcure Pharmaceuticals Share Price fell to Rs 1,870.50, down 3.27% today, taking the Large Cap Healthcare company’s market capitalisation to Rs 36,679.40 crore.

Emcure Pharmaceuticals Share Price is in focus today after the stock fell to Rs 1,870.50, down 3.27% from the previous close of Rs 1,933.75. With a market capitalisation of Rs 36,679.40 crore, Emcure Pharmaceuticals Ltd. remains a Large Cap name, and today’s move was notable enough to place it among the session’s tracked top decliners under a market-cap based price-fall screen.

For traders following Emcure Pharmaceuticals Share Price Today and investors scanning Emcure Pharmaceuticals Stock News, the key verified takeaway is straightforward: the stock recorded a meaningful same-day decline, traded in a wide intraday band, and ended near the lower end of that range. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the decline.

That still makes the move relevant. In a market where price action often draws attention before fresh disclosures appear, a 3.27% fall in a Large Cap stock can quickly move it into the Stocks in News bucket, especially when investors are also comparing sector valuations, peer positioning and the scale of the company against the broader Healthcare space. Univest notes that today’s move should be read through three lenses: the day’s trading structure, the company’s size within its sector, and how its scale compares with the benchmark and listed peers. Those factors together explain why Emcure Pharmaceuticals Share Price is trending in today’s market update.

Emcure Pharmaceuticals Ltd. (EMCURE) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,870.5
Previous Close	Rs 1,933.75
Today's Change	Rs -63.25 (-3.27%)
Day Open	Rs 1,910.6
Day High	Rs 1,938.4
Day Low	Rs 1,869.8
Current Volume (BSE)	14,371
BSE Traded Volume	14,371
NSE Traded Volume	2,07,521
Combined NSE + BSE Volume	2,21,892
Turnover	Rs 2.69 crore
Market Capitalisation	Rs 36,679.4 crore
Market Cap Category	Large Cap

Emcure Pharmaceuticals Ltd. (EMCURE) traded at Rs 1,870.5. versus the previous close of Rs 1,933.75, a fall of 3.27%. The stock opened at Rs 1,910.6, reached Rs 1,938.4, touched Rs 1,869.8. Reported volume was 14,371.

Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 36,679.4 crore

Emcure Pharmaceuticals Fundamental Analysis, based strictly on the supplied data, is centred mainly on company size and sector context rather than a full ratio set. The most concrete balance-sheet-scale signal available here is the company’s market capitalisation of Rs 36,679.40 crore, which places it well above the typical company size seen in the supplied Healthcare benchmark universe.

That market-cap number is important because market capitalisation indicates size, not quality, but size still shapes how the market interprets volatility. A 3.27% fall in a company valued at Rs 36,679.40 crore carries a different market signal from the same percentage move in a much smaller stock. In this case, Emcure Pharmaceuticals Share Price belongs to a company that is substantially larger than the benchmark’s median market capitalisation of Rs 135.27 crore and also far above the benchmark average of Rs 456.49 crore. It is even higher than the maximum market capitalisation of Rs 2,985.15 crore recorded in the supplied benchmark company set.

That scale tells investors two things. First, Emcure Pharmaceuticals Ltd. sits in a very different size band from most companies captured in the sector sample. Second, when a stock of this size appears in Top Losers Today or Stocks Falling Today screens, the move tends to attract wider attention simply because larger market-cap companies are tracked more closely by institutions, analysts and market participants.

Beyond market cap, the supplied data does not establish company-specific valuation multiples such as P/E ratio, P/B ratio or EV/EBITDA, nor profitability ratios such as ROE and ROCE for Emcure itself. That means the most disciplined way to read today’s move is through verified price action and the sector benchmark rather than through unsupported assumptions about earnings or valuation. Univest therefore treats Emcure Pharmaceuticals Share Price as a market-data driven event today: the stock has weakened meaningfully, the company remains large within the Healthcare universe, and the fall is significant enough to deserve monitoring even without a verified company-specific trigger in the data. That naturally leads into a sector-level check on where this stock sits in the broader Healthcare landscape.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.77x
Benchmark Average P/E	62.82x
Benchmark P/E Range	2.98x to 1,603.4x
Benchmark Median P/B	1.9x
Benchmark Median ROE	10.73%
Benchmark Median ROCE	13.16%
Company Market Capitalisation	Rs 36,679.4 crore
Benchmark Median Market Cap	Rs 135.27 crore

Emcure Pharmaceuticals Ltd. (EMCURE) is classified under sector: Healthcare.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

The Healthcare benchmark data gives useful context for Emcure Pharmaceuticals Share Price because it shows just how unusual the company’s size is within the supplied sector sample. It also helps frame the broader valuation environment in which investors are reading today’s price fall.

The sectorSnapshot covers the Healthcare sector and uses a benchmark scope described as the same sector, with 201 companies in the benchmark universe. Within that set, P/E data is available for 158 companies. The benchmark median P/E is 26.77, the average is 62.82, the minimum is 2.98 and the maximum is 1,603.40. For P/B, data is available for 200 companies, with a median of 1.90, average of 2.31, minimum of -22.08 and maximum of 27.19. Profitability is similarly spread out: median ROE is 10.73 and average ROE is 14.57 across 200 companies, while median ROCE is 13.16 and average ROCE is 17.03.

Those numbers show a sector with a wide dispersion in valuation and returns. In practical terms, Healthcare is not trading at one uniform multiple; instead, the benchmark contains everything from low-multiple companies to extremely high-multiple outliers. That matters for Emcure Pharmaceuticals Share Price News because it means today’s decline cannot be interpreted through a single sector-wide valuation narrative.

The market-cap distribution is even more striking. Across 201 companies, the median market capitalisation is Rs 135.27 crore and the average is Rs 456.49 crore, with a minimum of Rs 2.19 crore and a maximum of Rs 2,985.15 crore. Against that backdrop, Emcure Pharmaceuticals Ltd. at Rs 36,679.40 crore stands far above the displayed benchmark range. Univest views that as a key context point: Emcure’s price action is occurring in the Healthcare sector, but its scale is materially larger than the typical listed company represented in this benchmark snapshot. That makes the stock’s day move noteworthy not just as a price fall, but as a move in one of the sector’s much bigger market participants.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	184.72	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	68.16	6.74	18.65	22.17
Hikal Ltd.	HIKAL	2,686.72	0	2.26	15.22	16.15
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	46.15	1.77	-0.78	8.31
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,612.26	34.27	7.07	-2.6	16.92

Emcure Pharmaceuticals Ltd. (EMCURE) has a market capitalisation of Rs 36,679.4 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer set shows how Emcure Pharmaceuticals Share Price compares in market-cap terms with a group of Healthcare names spanning pharmaceuticals and hospital services. Even without company-specific valuation ratios for Emcure, the peer table helps place the stock’s scale and today’s price action in perspective.

The most immediate distinction is size. Emcure Pharmaceuticals Ltd. has a market capitalisation of Rs 36,679.40 crore, while the supplied peers range from Rs 2,388.41 crore for Venus Remedies Ltd. to Rs 2,985.15 crore for Dishman Carbogen Amcis Ltd. That means Emcure is dramatically larger than every company in the displayed peer basket. From a market-structure perspective, this is important because a 3.27% decline in a company of Emcure’s scale can draw more attention in Market News and Stock Updates than similar percentage moves in smaller peers.

Among the peers with P/E data, Dishman Carbogen Amcis trades at 184.72, Sai Parenteral’s at 171.00, Beta Drugs at 68.16, Fredun Pharmaceuticals at 58.41, Ind-Swift Laboratories at 46.15, Dr Agarwals Eye Hospital at 34.27 and Venus Remedies at 20.56. P/B values also vary meaningfully, from 0.45 for Dishman Carbogen Amcis to 8.73 for Fredun Pharmaceuticals. Profitability is equally mixed: Beta Drugs shows ROE of 18.65 and ROCE of 22.17, while Dishman Carbogen Amcis shows ROE of -2.89 and ROCE of -0.26. Ind-Swift Laboratories reports ROE of -0.78 and ROCE of 8.31, whereas Hikal shows ROE of 15.22 and ROCE of 16.15.

This broad spread reinforces a simple point for Emcure Pharmaceuticals Stock Analysis: the Healthcare space contains peers with very different valuation and return profiles. Since the supplied data does not include Emcure’s own P/E, P/B, ROE or ROCE, the cleanest conclusion is that the company stands out decisively on scale, while peer fundamentals across the sector are far from uniform. That makes today’s price fall a stock-specific trading event that investors will likely evaluate alongside future company disclosures, broader sector moves and continuing price action.

Why Investors Are Watching Emcure Pharmaceuticals

Emcure Pharmaceuticals Share Price is being watched because today’s move combined a clear same-day decline, Large Cap status and meaningful attention within the Healthcare pack. In market terms, this is the kind of session that can move a stock into the Top Losers Today conversation even when the supplied data does not identify a specific corporate trigger.

• Verified price action: the stock fell 3.27%, or Rs 63.25, from Rs 1,933.75 to Rs 1,870.50.
• Intraday structure: after opening at Rs 1,910.60 and reaching Rs 1,938.40, the stock slipped to Rs 1,869.80 and stayed near the low.
• Volume footprint: total volume reached 2,21,892 shares, with 2,07,521 shares on NSE and 14,371 on BSE.
• Size context: market capitalisation remains high at Rs 36,679.40 crore, keeping the move relevant across the Indian stock market.
• Sector lens: the company’s market cap is far above the supplied Healthcare benchmark median, average and displayed maximum.

For the next phase, investors are likely to monitor whether Emcure Pharmaceuticals Share Price stabilises away from the day’s low, whether fresh company news emerges, and how the stock behaves relative to broader Healthcare names. Univest also sees value in tracking whether this remains a one-session decline or develops into a larger trend in coming market updates.

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Ltd. is presented in the supplied market data as a listed company within the Healthcare sector. That sector classification alone is enough to place the stock in one of India’s most closely followed defensive and growth-linked market segments, where investors often compare pharmaceutical manufacturers, healthcare service providers and other medical businesses on valuation, profitability and scale.

The supplied benchmark universe shows that this sector includes companies such as Dishman Carbogen Amcis, Beta Drugs, Hikal, Ind-Swift Laboratories, Fredun Pharmaceuticals, Solara Active Pharma Sciences, Panacea Biotec and Venus Remedies in pharmaceuticals and drugs, along with Dr Agarwals Eye Hospital in hospital and healthcare services. That illustrates the breadth of the Healthcare basket within which Emcure Pharmaceuticals Share Price is being assessed today.

What stands out most from the available data is not a detailed business-segment breakdown, but the company’s scale. At Rs 36,679.40 crore in market capitalisation, Emcure Pharmaceuticals Ltd. is much larger than the companies listed in the supplied benchmarkCompanies and peerSnapshot sets. For readers following Emcure Pharmaceuticals Latest News, that means the stock’s price action often carries significance beyond a routine small-cap or micro-cap move. Univest therefore reads the company’s current market profile primarily through its large size within Healthcare and the way that scale shapes investor attention on days of notable price movement.

Track Emcure Pharmaceuticals Share Price on Univest

Use Emcure Pharmaceuticals Ltd. (EMCURE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors who want to follow Emcure Pharmaceuticals Share Price more closely can use Univest to track live price movement, market capitalisation, 52-week levels, share price updates and broader stock analysis tools in one place. For active market participants, that helps connect daily price action with longer-term context rather than looking at isolated sessions.

Univest also helps users monitor Emcure Pharmaceuticals Share Price Today alongside market insights, sector comparisons, peer metrics and company-level market data as it updates. That is especially useful on days like today, when the stock appears among top decliners and investors want a structured view of turnover, volume participation and sector positioning without jumping between multiple dashboards. In practical terms, Univest makes it easier to keep Emcure Pharmaceuticals Stock News and market context on a single research screen.

Frequently Asked Questions

Why did Emcure Pharmaceuticals Share Price fall today?

Ans. Emcure Pharmaceuticals Share Price fell 3.27% to Rs 1,870.50 from the previous close of Rs 1,933.75. The supplied data confirms the price fall and trading range, but it does not identify a company-specific catalyst.

What is Emcure Pharmaceuticals Share Price Today?

Ans. Emcure Pharmaceuticals Share Price Today is Rs 1,870.50. The stock was down Rs 63.25 on the session, after trading between an intraday high of Rs 1,938.40 and a low of Rs 1,869.80.

How much did Emcure Pharmaceuticals stock decline in percentage terms?

Ans. Emcure Pharmaceuticals stock declined 3.27% in today’s session. In rupee terms, that equals a fall of Rs 63.25 from the previous close of Rs 1,933.75 to the current price of Rs 1,870.50.

What does today’s intraday range show for Emcure Pharmaceuticals Share Price?

Ans. The intraday range shows early fluctuation followed by weakness. Emcure Pharmaceuticals Share Price opened at Rs 1,910.60, touched Rs 1,938.40, fell to Rs 1,869.80 and was trading close to that low later in the session.

What was the total traded volume in Emcure Pharmaceuticals today?

Ans. Total traded volume in Emcure Pharmaceuticals stood at 2,21,892 shares. NSE accounted for 2,07,521 shares and BSE accounted for 14,371 shares, showing that most visible trading activity was concentrated on the NSE.

What was the turnover recorded for Emcure Pharmaceuticals today?

Ans. The supplied trading data shows turnover of Rs 2.69 crore for Emcure Pharmaceuticals today. Along with the 3.27% decline and 2,21,892 total shares traded, that kept the stock on the market’s decliner radar.

What is the market capitalisation of Emcure Pharmaceuticals Ltd.?

Ans. Emcure Pharmaceuticals Ltd. has a market capitalisation of Rs 36,679.40 crore. That places it in the Large Cap category and makes today’s 3.27% share price decline notable in size-adjusted market screens.

Which sector does Emcure Pharmaceuticals belong to?

Ans. Emcure Pharmaceuticals belongs to the Healthcare sector according to the supplied market data. The same benchmark universe used here covers 201 Healthcare companies across a wide spread of valuation and profitability profiles.

How does Emcure Pharmaceuticals compare with the supplied Healthcare peers on size?

Ans. Emcure Pharmaceuticals stands out strongly on scale. Its market capitalisation is Rs 36,679.40 crore, while the supplied peers range from Rs 2,388.41 crore to Rs 2,985.15 crore, making Emcure much larger than that basket.

Why is Emcure Pharmaceuticals stock in focus on Univest today?

Ans. Univest is tracking Emcure Pharmaceuticals because the stock fell 3.27%, traded near its day’s low of Rs 1,869.80, and belongs to the Large Cap Healthcare segment where price action often draws broader attention.